Trinity Biotech, the Irish-founded medical diagnostics company, has agreed a deal to sell its life sciences supply business to Biosynth for $30 million .
The Nasdaq-listed firm said the deal for its Fitzgerald Industries businesses, is expected to close by the end of the month. Bray-headquartered Trinity develops, manufactures and markets diagnostic systems for the point-of-care and clinical laboratory segments of the diagnostic market. Its products are sold in more than 110 countries, and ...
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: